Potency of descending pain modulatory system is linked with peripheral sensory dysfunction in fibromyalgia : An exploratory study

• Autor(a) principal: Brietzke, Aline Patrícia
• Data de Publicação: 2019
• Outros Autores: Antunes, Luciana da Conceição, Carvalho, Fabiana, Elkfury, Jéssica Lorenzzi, Gasparin, Assunta, Sanches, Paulo Roberto Stefani, Silva Junior, Danton Pereira da, Sarria, Jairo Alberto Dussán, Souza, Andressa de, Torres, Iraci Lucena da Silva, Fregni, Felipe, Caumo, Wolnei
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Institucional da UFRGS
• Texto Completo: http://hdl.handle.net/10183/198910
• topic: Fibromialgia; Limiar da dor; Fator neurotrófico derivado do encéfalo

Fibromyalgia (FM) is characterized by chronic widespread pain whose pathophysiological mechanism is related to central and peripheral nervous system dysfunction. Neuropathy of small nerve fibers has been implicated due to related pain descriptors, psychophysical pain, and neurophysiological testing, as well as skin biopsy studies. Nevertheless, this alteration alone has not been previously associated to the dysfunction in the descending pain modulatory system (DPMS) that is observed in FM. We hypothesize that they associated, thus, we conducted a cross-sectional exploratory study. To explore small fiber dysfunction using quantitative sensory testing (QST) is associated with the DPMS and other surrogates of nociceptive pathways alterations in FM. We run a cross-sectional study and recruited 41 women with FM, and 28 healthy female volunteers. We used the QST to measure the thermal heat threshold (HTT), heat pain threshold (HPT), heat pain tolerance (HPT), heat pain tolerance (HPTo), and conditional pain modulation task (CPM-task). Algometry was used to determine the pain pressure threshold (PPT). Scales to assess catastrophizing, anxiety, depression, and sleep disturbances were also applied. Serum brain-derived neurotrophic factor (BDNF) was measured as a marker of neuroplasticity. We run multivariate linear regression models by group to study their relationships. Samples differed in their psychophysical profile, where FM presented lower sensitivity and pain thresholds. In FM but not in the healthy subjects, regression models revealed that serum BDNF was related to HTT and CPM-Task (Hotelling Trace=1.80, P<.001, power=0.94, R2=0.64). HTT was directly related to CPM-Task (B=0.98, P=.004, partial-n2=0.25), and to HPT (B=1.61, P=.008, partial n2=0.21), but not to PPT. Meanwhile, BDNF relationship to CPM-Task was inverse (B=–0.04, P=.043, partial-n2=0.12), and to HPT was direct (B=–0.08, P=.03, partial-n2=0.14). These findings high spot that in FM the disinhibition of the DPMS is positively correlated with the dysfunction in peripheral sensory neurons assessed by QST and conversely with serum BDNF. Abbreviations: ACR = American College of Rheumatology, BDI-II = Beck Depression Inventory, BDNF = brain-derived neurotrophic factor, BP-PCS = Brazilian Portuguese Catastrophizing Scale, CPM-task = conditional pain modulation task, DPMS = descending pain modulatory system, ELISA = Enzyme-Linked Immunosorbent Assay, FIQ = Fibromyalgia Impact Questionnaire, FM = Fibromyalgia, HCPA = Hospital de Clinicas de Porto Alegre, HPT = heat pain threshold, HPTO = heat pain tolerance, HTT = thermal heat threshold, LTD = long term depression, NGF = neural growth factor, NMDA = N-methyl-D-aspartate, NPS = numerical pain scale, NRM = nucleus raphe magnus, PKC = Protein kinase C, PPT = pain pressure threshold, PSQI = Pittsburgh Sleep Quality Index, QST = quantitative sensory testing, STAI = State-Trait Anxiety Inventory, STT = spinothalamic tract, tDCS = transcranial direct.